Skip to content

Tomas Kiselak, Director at Oruka Therapeutics, sold ORKA on Jul 1, 2026

Data as of Oct 16

▼ SELL$300M3,553,410 shares at $84.43Tomas Kiselak DirectorORKA Oruka Therapeutics, Inc.
Watch ORKA
Traded
Jul 1, 2026
Disclosed
Jul 1, 2026
Filed
The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Tomas Kiselak, Director at Oruka Therapeutics, sold ORKA on Jul 1, 2026TRADEDDISCLOSED
ORKASimilar stocks (XLV — its sector index fund), rebased to ORKA's price on the disclosure day
ORKA since disclosure
−22.9%
after the sale
Similar stocks (XLV) since disclosure
+10.8%
XLV — its sector index fund

Change in closing price from Jul 1, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLFairmount Funds Management LLC DirectorORKA Oruka Therapeutics, Inc.$300Mdisclosed Jul 1 · filed the same day
  2. ▼ SELLFairmount Healthcare Fund II L.P. DirectorORKA Oruka Therapeutics, Inc.$300Mdisclosed Jul 1 · filed the same day
  3. ▼ SELLPeter Evan Harwin DirectorORKA Oruka Therapeutics, Inc.$300Mdisclosed Jul 1 · filed the same day
  4. ▼ SELLFairmount Healthcare Co-Invest III L.P. DirectorORKA Oruka Therapeutics, Inc.$300Mdisclosed Jul 1 · filed the same day

See every trade on ORKA →